{
    "title": "110_s3549",
    "content": "The \"QI Program Supplemental Funding Act of 2008\" increases funding for the Qualifying Individual (QI) Program under the Social Security Act. The funding is amended to $315,000,000 for subparagraph (I) and $130,000,000 for subparagraph (J). Additionally, the Act mandates the use of the State Public Assistance Reporting Information System (PARIS) Project. The Social Security Act is amended to require states to have an eligibility determination system that includes data matching through the Public Assistance Reporting Information System (PARIS) for medical assistance programs. The effective date for these amendments is October 1, 2009. The Social Security Act was amended in 2009 to extend the effective date for state law amendments related to Medicaid eligibility requirements. States are given leeway to meet these additional requirements after the first regular session of the State legislature following the enactment of the Act. During each legislative session, each year is considered a separate regular session of the State legislature. SEC. 4. Incentives for the development and access to certain antibiotics. Incentives for the development and access to certain antibiotics include a provision for antibiotic drugs approved before November 21, 1997 to be eligible for a 3-year exclusivity period. Antibiotic drugs approved before November 21, 1997 may be eligible for a 3-year exclusivity period under certain conditions. This applies to applications for marketing submitted after the enactment of this subsection containing specific antibiotic drugs approved by the Secretary before November 21, 1997. Antibiotic drugs submitted before November 21, 1997 may be eligible for a 3-year exclusivity period under certain conditions. This allows sponsors of such drugs to elect for exclusivity periods as specified in the FDA Modernization Act of 1997. The FDA Modernization Act of 1997 allows for a 5-year exclusivity period or a patent term extension for antibiotic drugs submitted after the enactment of the subsection. The FDA Modernization Act of 1997 provides exclusivity and extensions for antibiotic drugs that were not approved under previous applications. The FDA Modernization Act of 1997 provides exclusivity and extensions for antibiotic drugs, excluding certain conditions of use approved before the enactment of the subsection. The Drug Price Competition and Patent Term Restoration Act of 1984 provisions apply to drugs subject to certain conditions, with transitional rules for patents issued before the enactment of the Act. The Drug Price Competition and Patent Term Restoration Act of 1984 requires the Secretary to publish patent information within 90 days of enactment, with applicants given 120 days to amend applications. Before the enactment of this Act, a complete application to include a certification for a patent will be considered a first applicant. SEC. 5. CLARIFICATION OF AUTHORITY FOR USE OF MEDICAID INTEGRITY PROGRAM FUNDS. Section 1936 of the Social Security Act is amended to clarify the authority for the use of funds for education or training at conferences for State or local officers responsible for Medicaid administration. Amounts appropriated shall remain available until expended. The Secretary may use funds for transportation and travel expenses for attendees at education, training, or consultative activities. The Secretary may use funds for transportation and travel expenses for attendees at education, training, or consultative activities. The amendments made by paragraph (1) shall take effect as if included in the enactment of section 1936 of the Social Security Act. The Secretary shall make public disclosure on a website accessible to the public. The amendment requires public disclosure of funds spent on conferences under the Social Security Act, specifically for transportation and travel expenses. It applies to conferences conducted after the enactment of the Act. The amendment allocates funding to the Medicare Improvement Fund for services provided during fiscal years 2014 through 2017, totaling $19.9 billion."
}